{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T13:06:15Z","timestamp":1648731975829},"reference-count":18,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.thromres.2004.06.041","type":"journal-article","created":{"date-parts":[[2004,8,5]],"date-time":"2004-08-05T15:25:56Z","timestamp":1091719556000},"page":"3-8","source":"Crossref","is-referenced-by-count":1,"title":["Evidence based treatment of the antiphospholipid syndrome"],"prefix":"10.1016","volume":"115","author":[{"given":"Mark A.","family":"Crowther","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Finn","family":"Wisloff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.thromres.2004.06.041_bib1","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0002-9343(98)00060-6","article-title":"Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group","volume":"104","author":"Schulman","year":"1998","journal-title":"Am. J. Med."},{"issue":"12","key":"10.1016\/j.thromres.2004.06.041_bib2","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJM199903253401201","article-title":"A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism","volume":"340","author":"Kearon","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.thromres.2004.06.041_bib3","first-page":"490","article-title":"Longterm anticoagulation is preferable for patients with antiphospholipid antibody syndrome. Result of a decision analysis","volume":"29","author":"Brunner","year":"2002","journal-title":"J. Rheumatol."},{"issue":"3","key":"10.1016\/j.thromres.2004.06.041_bib4","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0889-857X(05)70225-8","article-title":"Management of thrombosis in antiphospholipid antibody syndrome","volume":"27","author":"Petri","year":"2001","journal-title":"Rheum. Dis. Clin. North Am."},{"issue":"1 Suppl.","key":"10.1016\/j.thromres.2004.06.041_bib5","doi-asserted-by":"crossref","first-page":"8S","DOI":"10.1378\/chest.119.1_suppl.8S","article-title":"Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range","volume":"119","author":"Hirsh","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2004.06.041_bib6","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJM199504133321504","article-title":"The management of thrombosis in the antiphospholipid\u2013antibody syndrome","volume":"332","author":"Khamashta","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2004.06.041_bib7","doi-asserted-by":"crossref","first-page":"303","DOI":"10.7326\/0003-4819-117-4-303","article-title":"Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients","volume":"117","author":"Rosove","year":"1992","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.thromres.2004.06.041_bib8","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1056\/NEJMoa035241","article-title":"A randomized trial of two intensities of warfarin (international normalized ratio of 2.0 to 3.0 versus 3.1 to 4.0) for the prevention of recurrent thrombosis in patients with antiphospholipid antibodies","volume":"349","author":"Crowther","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"s1","key":"10.1016\/j.thromres.2004.06.041_bib9","first-page":"OC365","article-title":"A randomized clinical trial of oral anticoagulant therapy in patients with antiphospholipid antibody syndrome: the WAPS study","volume":"1","author":"Finazzi","year":"2003","journal-title":"J. Thromb. Haemost."},{"issue":"7372","key":"10.1016\/j.thromres.2004.06.041_bib10","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1136\/bmj.325.7372.1073","article-title":"Oral anticoagulation and risk of death: a medical record linkage study","volume":"325","author":"Oden","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2004.06.041_bib11","unstructured":"Kearon C, Ginsberg JS, Anderson DR, Kovacs MJ, Wells PS, Julian J, et al. Comparison of one month with three months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. Submitted to Annals of Internal Medicine. 2003."},{"key":"10.1016\/j.thromres.2004.06.041_bib12","unstructured":"Kearon C, Ginsberg JS, Kovacs MJ, Anderson D, Wells PS, Julian J, et al. Low-intensity (INR 1.5\u20131.9) versus conventional-intensity (INR 2.0\u20133.0) anticoagulation for extended treatment of unprovoked VTE: a randomized double blind trial. Blood 100[11(s1)], 150a (Abs 562). 2002."},{"issue":"5","key":"10.1016\/j.thromres.2004.06.041_bib13","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1001\/jama.291.5.576","article-title":"Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke","volume":"291","author":"Levine","year":"2004","journal-title":"JAMA"},{"issue":"20","key":"10.1016\/j.thromres.2004.06.041_bib14","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJMoa011258","article-title":"A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke","volume":"345","author":"Mohr","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2004.06.041_bib15","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJM199709043371002","article-title":"A comparison of low-molecular weight heparin with unfractionated heparin for acute pulmonary embolism","volume":"337","author":"Simonneau","year":"1997","journal-title":"N. Engl. J. Med."},{"issue":"9327","key":"10.1016\/j.thromres.2004.06.041_bib16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0140-6736(02)09409-6","article-title":"Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial","volume":"360","author":"van Es","year":"2002","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.thromres.2004.06.041_bib17","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJMoa020496","article-title":"Warfarin, aspirin, or both after myocardial infarction","volume":"347","author":"Hurlen","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.thromres.2004.06.041_bib18","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMra002974","article-title":"The antiphospholipid syndrome","volume":"346","author":"Levine","year":"2002","journal-title":"N. Engl. J. Med."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384804003500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384804003500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T03:53:55Z","timestamp":1549338835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384804003500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":18,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0049384804003500"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2004.06.041","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}